loader
Please Wait
Applying Filters...

Annual Sales of Letermovir reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 12,777Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Prevymis

PharmaCompass

01

Brand Name : Prevymis

Letermovir

arrow
Discovery on Target
Not Confirmed

Brand Name : Prevymis

arrow
Discovery on Target
Not Confirmed

Letermovir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 281

2019 Revenue in Millions : 0

Growth (%) : 100

blank

02

Brand Name : Prevymis

Letermovir

arrow
Discovery on Target
Not Confirmed

Brand Name : Prevymis

arrow
Discovery on Target
Not Confirmed

Letermovir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 370

2020 Revenue in Millions : 281

Growth (%) : 32

blank

03

Brand Name : Prevymis

Letermovir

arrow
Discovery on Target
Not Confirmed

Brand Name : Prevymis

arrow
Discovery on Target
Not Confirmed

Letermovir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 428

2021 Revenue in Millions : 370

Growth (%) : 16

blank

04

Brand Name : Prevymis

Letermovir

arrow
Discovery on Target
Not Confirmed

Brand Name : Prevymis

arrow
Discovery on Target
Not Confirmed

Letermovir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 605

2022 Revenue in Millions : 428

Growth (%) : 41

blank